ALNY

#340
Alnylam Pharmaceuticals, Inc. - Common Stock
301.9 7 USD
-0.73%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
297.62
302.68
Range Annuel
284.28
495.55
Changement quotidien
-0.73%
Changement Mensuel
-1.79%
Evolution sur 6 mois
-32.88%
Changement Annuel
+5.14%
Clôture Précédente
304.2 0
Open
297.7 2
Low
297.6 2
High
302.6 8
Volume
1 979
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Alnylam Pharmaceuticals, Inc. - Common Stock

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.

Nouvelles